文章名稱引用次數

• ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis96
• Recommendations for cognitive screening and management in multiple sclerosis care42
• Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study41
• Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod37
• Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis32
• Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment25
• Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis25
• High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial20
• Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study20
• Remotely supervised transcranial direct current stimulation for the treatment of fatigue in multiple sclerosis: Results from a randomized, sham-controlled trial18